Daymark Health is a value-based oncology company redefining the cancer care experience for patients, providers, and health plans. Daymark’s comprehensive, personalized cancer care platform empowers patients with dedicated care navigation, symptom-focused support, behavioral health care, and social resources. Combined with evidence-based health interventions and a hybrid in-person + virtual care model, Daymark is improving the overall cancer experience for patients, providers, and health plans – and setting a new standard in cancer care.
Daymark’s groundbreaking approach is led by CEO Dr. Justin Bekelman, a pioneer in transforming cancer care, alongside some of the nation’s foremost leaders in oncology and value-based care. Daymark Health is backed by Maverick Ventures, Yosemite, Oncology Ventures, Healthier Capital, Blue Venture Fund, and Healthcare Foundry.
Be cautious of recruitment fraud, and always confirm that communications are coming from an official Daymark Health email.
This is an opportunity to join Daymark's Medical Economics function as a key early hire on the team, working closely with our VP of Medical Economics to scale the cost-of-care analytics function. You'll help own execution across payer-facing savings dashboards and internal utilization reporting, built on top of Daymark's data infrastructure.
The role starts as a hands-on individual contributor role with room to grow as the team scales, ideal for someone who wants to build deep analytical expertise while contributing to strategic decisions alongside senior leadership.
WHAT YOU'LL DO
Medical Economics & Contract Performance
Own total cost-of-care analytics across all payer contracts, including PMPM, utilization, and service grouper categories on top of Tuva infrastructure.
Develop shared savings calculations, baseline and trend construction, and member mix and service mix adjustment approaches that normalize costs across cancer types and acuity cohorts, ensuring adjustments are transparent, reproducible, and defensible to plan counterparts.
Translate the effectiveness of our clinical model’s inputs into outputs, both to drive improvement in our model in coordination with our clinical operations leadership, and attribute value generation from the program on behalf of our plan partners
Lead reporting with payer partners and serve as Daymark's analytical counterpart to plan medical economics and actuarial teams.
Reporting Infrastructure
Build and own Daymark's internal and external reporting stack, from payer-facing savings dashboards to internal trend and utilization reports.
Collaborate with Product and Engineering on data model and agentic workflow development to support medical economics and reporting infrastructure.
AI & Advanced Analytics
Lead Daymark's medical economics AI strategy, identifying high-value use cases for LLM and agentic workflows in claims analytics and reporting automation.
Build AI tooling infrastructure and develop agentic EHR monitoring workflows to support proactive care pathway identification.
Payer Growth Contracting Support
Support claims-based opportunity assessments for new payer partnerships, including cost and utilization benchmarking and savings lever identification
Serve as Daymark's analytical voice in payer negotiations, defending savings estimates, attribution methodology, and other term requirements
Team & Organization
Embrace a lean and fast growing medical economics and reporting function, operating as a hands-on individual contributor
Collaborate with Daymark's actuary and finance team on modeling, trending, and actuarial review
Additional Information
The expected compensation for this role is $150,000 to $180,000 annually, depending on location & experience.
This role is fully remote but will operate on either Central or Eastern time business hours.
Daymark Health is a value-based oncology company that redefines the cancer care experience through a comprehensive, personalized platform combining dedicated care navigation, symptom-focused support, behavioral health care, and social resources. The company leverages evidence-based health interventions and a hybrid in-person plus virtual care model to improve outcomes for patients, providers, and health plans. Led by CEO Dr. Justin Bekelman and oncology experts, Daymark is setting a new standard in cancer care delivery. The company is backed by prominent venture capital firms including Maverick Ventures, Yosemite, Oncology Ventures, Healthier Capital, Blue Venture Fund, and Healthcare Foundry.
